Brett Guthrie

Mr. GUTHRIE

Mr. GUTHRIE. Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, I thank my colleagues, Environment Subcommittee Chairman Palmer and Ranking Member Tonko, for introducing H.R. 9617, the Coordinating and Harnessing America's Recovery of Minerals Act, or CHARM Act. Throughout this Congress, our committee has examined opportunities to recover critical minerals from discarded materials, such as mine waste, coal combustion materials, end-of-life electronics, and produced water. The CHARM Act is a product of a lot of this work. This bill directs the EPA, in consultation with Federal agencies, to develop a national critical mineral recovery strategy in coordination with other Federal agencies. EPA already has the expertise in recovery of valuable materials from discarded materials, and the agency is well-positioned to lead these efforts. Mr. Speaker, I urge my colleagues in the House to support the passage of this bipartisan legislation. I appreciate the hard work of Chairman Palmer and Ranking Member Tonko, and I reserve the balance of my time.

Mr. GUTHRIE. Mr. Speaker, I ask unanimous consent that all Members may have 5 legislative days to revise and extend their remarks on the legislation and to include extraneous material on H.R. 9617.

Mr. GUTHRIE. Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 9617) to amend the Solid Waste Disposal Act to direct the Administrator of the Environmental Protection Agency to coordinate a National Critical Mineral Recovery Strategy, and for other purposes.

Mr. GUTHRIE

Mr. GUTHRIE. Mr. Speaker, I appreciate the hard work of my friend from Colorado. I encourage a ``yes'' vote on the bill, and I yield back the balance of my time.

Mr. GUTHRIE. Mr. Speaker, I yield 3 minutes to the gentleman from Colorado (Mr. Evans), who is a tireless fighter on this issue and a very valuable member of the Energy and Commerce Committee.

Mr. GUTHRIE. Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, I rise today in strong support of H.R. 8005, the Stop Pills That Kill Act, that my good friend from Colorado (Mr. Evans) has brought forward. The threat posed by illicit pill presses has risen as drug traffickers continue to press fentanyl, methamphetamine, and other illicit drugs into drug pills. In 2025 alone, DEA seized over 47 million fentanyl-laced counterfeit pills. This bill makes important regulatory changes to strengthen DEA's ability to stop bad actors from misusing pill presses, tableting, and encapsulating machines and their critical components to illicitly manufacture controlled substances to poison our communities. This bill will make our streets safer. I applaud the tireless efforts of my friend from Colorado to protect Americans from these threats. Mr. Speaker, I encourage my colleagues to support this bill, and I reserve the balance of my time.

Mr. GUTHRIE. Mr. Speaker, I ask unanimous consent that all Members may have 5 legislative days to revise and extend their remarks on the legislation and include extraneous material on H.R. 8005.

Mr. GUTHRIE. Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 8005) to amend the Controlled Substances Act to prohibit certain acts related to fentanyl, analogues of fentanyl, and counterfeit substances, and for other purposes, as amended.

Mr. GUTHRIE

Mr. GUTHRIE. Mr. Speaker, I appreciate all of the moms who have been working with us. We really appreciate their hard work. Our sympathies are with them, and we are glad that their children are being honored tonight. This is final passage, and we have been working on this for quite a while. Mr. Speaker, I encourage a ``yes'' vote on the bill, I look forward to voting for it in just a couple of seconds, and I yield back the balance of my time.

Mr. GUTHRIE. Mr. Speaker, I reserve the balance of my time.

Mr. GUTHRIE. Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, I rise today in strong support of H.R. 2004, led by the gentleman from California (Mr. Lieu) and the gentleman from Ohio (Mr. Latta). Tyler's Law is named after Tyler Shamash, who suffered from a fatal fentanyl poisoning after doctors did not test for fentanyl when he was admitted to the hospital emergency room. This bill would honor Tyler's memory by helping prevent more tragedies and ensuring providers are able to provide the best practices when treating cases of potential drug overdoses. I encourage my colleagues to vote for this bill. I can't stop, Mr. Speaker, without bringing up his mother, Juli, who has spent tireless hours flying from California to D.C.--sometimes, because of our schedule change, on a moment's notice--to be present for hearings and bringing this story, knowing that it is not going to bring her son back but wanting to prevent other mothers and other people from going through what she has gone through. I appreciate her hard work, and I acknowledge that. I encourage my colleagues to support this bill to honor his legacy and the many families who have suffered similarly. I reserve the balance of my time.

Mr. GUTHRIE. Mr. Speaker, I ask unanimous consent that all Members may have 5 legislative days to revise and extend their remarks and include extraneous material on H.R. 2004.

Mr. GUTHRIE. Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 2004) to direct the Secretary of Health and Human Services to issue guidance on whether hospital emergency departments should implement fentanyl testing as a routine procedure for patients experiencing an overdose, and for other purposes.

Mr. GUTHRIE

Mr. GUTHRIE. Mr. Speaker, I appreciate my friend from California's hard work on this bill and all the other colleagues he mentioned and the committee's work. I encourage a ``yes'' vote on this bill, and I yield back the balance of my time.

Mr. GUTHRIE. I have no further speakers on this bill. I reserve the balance of my time.

Mr. GUTHRIE. Mr. Speaker, I reserve the balance of my time.

Mr. GUTHRIE. Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, I rise today in strong support of H.R. 1266, the Combating Illicit Xylazine Act, led by my colleagues Representatives Panetta and Pfluger. Xylazine is a veterinary drug used to sedate large animals. It has no legitimate use in humans, and it is quickly becoming one of the deadliest drugs on our streets. This bill would place xylazine in schedule III of the Controlled Substances Act while ensuring an exemption for appropriate use within the veterinary and ranching industries. The decision to place xylazine in schedule III is a product of extensive bipartisan work spanning two Congresses and two administrations, supported by both DEA and HHS. It is critical that we pass this commonsense bill to strengthen our ability to crack down on illicit xylazine distribution while preserving its legitimate veterinary and ranching uses. Mr. Speaker, I encourage my colleagues to support this bill, and I reserve the balance of my time.

Mr. GUTHRIE. Mr. Speaker, I ask unanimous consent that all Members may have 5 legislative days to revise and extend their remarks on the legislation and to include extraneous material on H.R. 1266.

Mr. GUTHRIE. Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 1266) to prohibit certain uses of xylazine, and for other purposes, as amended.

Mr. GUTHRIE

Mr. GUTHRIE. Mr. Speaker, Mr. Smith of New Jersey has worked tirelessly on this. It is important. Vector-borne tick diseases and these others have just spread in the last few years. Mr. Speaker, I encourage a ``yes'' vote on this bill, and I yield back the balance of my time.

Mr. GUTHRIE. Mr. Speaker, I yield 5 minutes to the gentleman from New Jersey (Mr. Smith), a tireless worker on this issue and my good friend.

Mr. GUTHRIE. Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, I rise today in strong support of S. 2398, the Senate companion to bipartisan legislation recently advanced by the Committee on Energy and Commerce led by Senator Collins and Congressman Chris Smith of New Jersey. Vectors such as mosquitos, ticks, and fleas can carry life- threatening diseases, and anyone can contract a vector-borne disease with potentially debilitating consequences. This bill reauthorizes the National Strategy and Regional Centers of Excellence in Vector-Borne Diseases, as well as the CDC's cooperative agreements with health departments in high-risk areas for vector-borne diseases. Preventing these diseases and responding to vector-borne threats is a bipartisan issue that I hope we can all support. Mr. Speaker, I encourage my colleagues to vote in favor of the bill, and I reserve the balance of my time.

Mr. GUTHRIE. Mr. Speaker, I ask unanimous consent that all Members may have 5 legislative days to revise and extend their remarks on the legislation and to include extraneous material on S. 2398.

Mr. GUTHRIE. Mr. Speaker, I move to suspend the rules and pass the bill (S. 2398) to reauthorize the Kay Hagan Tick Act, and for other purposes.

Mr. GUTHRIE

Mr. GUTHRIE. Mr. Speaker, I appreciate my friend from Florida (Mr. Bilirakis) and my friend from Michigan (Mrs. Dingell) for working together to get us to a point where we could pass this bill today, just as we heard Mr. Grothman from Wisconsin say how important this bill is. Mr. Speaker, I encourage a ``yes'' vote on this bill, and I yield back the balance of my time.